TNFSF13B and fatty liver disease: Assessment of liver steatosis revealed alanine transaminase levels were similar between the two groups (Supplementary Figure 6B), but liver triglyceride levels were significantly increased in the anti-BAFF Ab-treated mice (Figure 3I).